US Broker Ratings

TruBridge, Inc. (TBRG) Stock Analysis: Navigating Healthcare Tech with a 12.43% Potential Upside

TruBridge, Inc. (NASDAQ: TBRG) is a notable player in the healthcare sector, specifically within the health information services industry. Headquartered in Mobile, Alabama, TruBridge has carved a niche in providing..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Unveiling a 53.59% Potential Upside with Strategic Partnerships

CytomX Therapeutics, Inc. (CTMX), a pioneering force in the biotechnology sector, is making waves in the oncology-focused biopharmaceutical landscape. With a market capitalization of approximately $896.31 million, the company is..

Lyft, Inc. (LYFT) Investor Outlook: Assessing a 30.95% Potential Upside Amid Sector Challenges

Lyft, Inc. (LYFT), a prominent player in the technology sector, operates within the software application industry, providing a peer-to-peer marketplace for on-demand ridesharing in the United States and Canada. While..

SANUWAVE Health, Inc. (SNWV)

⚠️ No article content returned.

..

Nyxoah SA (NYXH) Investor Outlook: Exploring a 137.85% Potential Upside in the Healthcare Sector

Nyxoah SA (NASDAQ: NYXH), a Belgium-based innovator in the medical technology space, is garnering interest from investors due to its robust growth potential and strategic focus within the healthcare sector...

Shopify Inc. (SHOP) Stock Analysis: A 29.56% Potential Upside and Key Analyst Ratings

Shopify Inc. (SHOP) is capturing the spotlight in the world of technology stocks, thanks to its robust market presence and significant growth potential. Trading on the New York Stock Exchange,..

Phathom Pharmaceuticals (PHAT): Investor Outlook on a Biotech with 68% Potential Upside

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a burgeoning entity in the biotechnology sector, focusing on innovative treatments for gastrointestinal diseases. With a market capitalization of $1.06 billion, the company has..

Viemed Healthcare, Inc. (VMD) Stock Analysis: A 73.56% Potential Upside Awaits Investors

For investors with a keen eye on growth opportunities in the healthcare sector, Viemed Healthcare, Inc. (VMD) presents an intriguing proposition. With an enticing potential upside of 73.56%, as indicated..

UroGen Pharma Ltd. (URGN) Stock Analysis: Investors Eye 83% Upside Amid Biotech Innovations

UroGen Pharma Ltd. (NASDAQ: URGN) is making waves in the biotechnology sector, standing out with its promising innovations in urothelial and specialty cancers. With the current stock price at $19.23,..

XOMA Royalty Corporation (XOMA): Investor Outlook Reveals a Compelling 136% Potential Upside

XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing prospect for investors with a focus on the biotechnology sector. As a dedicated royalty aggregator, XOMA has carved out a unique niche..

Cidara Therapeutics, Inc. (CDTX) Stock Analysis: Navigating the Biotech Landscape with Potential Upside

Cidara Therapeutics, Inc. (NASDAQ: CDTX), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling serious diseases. Operating out of San Diego, California, this..

Varex Imaging Corporation (VREX) Investor Outlook: 21.55% Potential Upside and Robust Revenue Growth

For investors eyeing opportunities in the healthcare sector, Varex Imaging Corporation (NASDAQ: VREX) presents an intriguing proposition. With a market capitalization of $593.16 million, Varex operates in the medical devices..

Sprout Social, Inc (SPT) Stock Analysis: A Look at Its 64% Potential Upside in a Competitive Market

Sprout Social, Inc. (NYSE: SPT), with its current stock price at $9.51, presents an intriguing opportunity for investors, particularly given its potential upside of 64.04% based on the average target..

Gossamer Bio, Inc. (GOSS) Investor Outlook: Biotech Stock Poised for 246.72% Upside with Promising PAH Treatment

Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company that has captured the attention of investors with its innovative approach to treating pulmonary arterial hypertension (PAH). As a key..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Gem with 95.98% Potential Upside

Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company, has caught the attention of investors with its impressive potential upside of nearly 96%. Operating in the healthcare sector and specializing in..

Neurogene Inc. (NGNE) Stock Analysis: Unpacking a 222% Upside Potential in Biotechnology

Neurogene Inc. (NASDAQ: NGNE), a promising player in the biotechnology sector, is catching the attention of investors with its substantial upside potential of 222.23%. Specializing in genetic medicines for rare..

Cartesian Therapeutics, Inc. (RNAC): Stock Analysis Reveals a Staggering 365% Potential Upside

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) is capturing the attention of investors in the biotechnology sector, driven by its innovative approach to mRNA cell therapies for autoimmune diseases. With a current..

Marti Technologies, Inc. (MRT): An Investor Outlook on a High-Growth, High-Upside Turkish Tech Innovator

Marti Technologies, Inc. (NASDAQ: MRT), a burgeoning player in Turkey’s urban mobility landscape, is capturing investor interest with its impressive revenue growth and substantial potential upside. As a tech-driven company..

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring the 161.64% Potential Upside in the Medical Devices Sector

Senseonics Holdings, Inc. (SENS) stands at a captivating juncture in the healthcare sector, particularly within the medical devices industry. This Germantown, Maryland-based company is making significant strides with its innovative..

Nerdy Inc. (NRDY) Stock Analysis: Exploring a Potential 110% Upside in the EdTech Arena

Investors with an eye on the educational technology sector should take note of Nerdy Inc. (NRDY), a company that has carved out a niche in live online learning. With its..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds